These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 31423846)

  • 1. Inhibitory effects of flavonoids isolated from
    Kwon M; Ko SK; Jang M; Kim GH; Ryoo IJ; Son S; Ryu HW; Oh SR; Lee WK; Kim BY; Jang JH; Ahn JS
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1481-1488. PubMed ID: 31423846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kushenol A and 8-prenylkaempferol, tyrosinase inhibitors, derived from Sophora flavescens.
    Kim JH; Cho IS; So YK; Kim HH; Kim YH
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1048-1054. PubMed ID: 29873272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis and Biological Evaluation of Novel 1,2,5-Oxadiazol-3- Carboximidamide Derivatives as Indoleamine 2, 3-Dioxygenase 1 (IDO1) Inhibitors.
    Xia Z; Nan Y; Liu C; Lin G; Gu K; Chen C; Zhao W; Ju D; Dong X
    Anticancer Agents Med Chem; 2020; 20(13):1592-1603. PubMed ID: 32496990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and Characterisation of Dual Inhibitors of Tryptophan 2,3-Dioxygenase (TDO2) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Using Virtual Screening.
    Sari S; Tomek P; Leung E; Reynisson J
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31795096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of indole-2-carboxylic acid derivatives as IDO1/TDO dual inhibitors.
    Cui G; Lai F; Wang X; Chen X; Xu B
    Eur J Med Chem; 2020 Feb; 188():111985. PubMed ID: 31881488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and comparison of the commonly used bioassays of human indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO).
    Zhang S; Guo L; Yang D; Xing Z; Li W; Kuang C; Yang Q
    Bioorg Chem; 2020 Nov; 104():104348. PubMed ID: 33142415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of IDO1 and DNA dual targeting antitumor agents.
    Fang K; Wu S; Dong G; Wu Y; Chen S; Liu J; Wang W; Sheng C
    Org Biomol Chem; 2017 Dec; 15(47):9992-9995. PubMed ID: 29177308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biological evaluation of a novel indoleamine 2,3-dioxigenase 1 (IDO1) and thioredoxin reductase (TrxR) dual inhibitor.
    Fan QZ; Zhou J; Zhu YB; He LJ; Miao DD; Zhang SP; Liu XP; Zhang C
    Bioorg Chem; 2020 Dec; 105():104401. PubMed ID: 33113415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel hydroxyamidine derivatives as indoleamine 2,3-dioxygenase 1 inhibitors with in vivo anti-tumor efficacy.
    Liu C; Nan Y; Xia Z; Gu K; Chen C; Dong X; Ju D; Zhao W
    Bioorg Med Chem Lett; 2020 Apr; 30(8):127038. PubMed ID: 32088128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and Synthesis of Indoleamine 2,3-Dioxygenase 1 Inhibitors and Evaluation of Their Use as Anti-Tumor Agents.
    Wen H; Liu Y; Wang S; Wang T; Zhang G; Chen X; Li Y; Cui H; Lai F; Sheng L
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31195673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The [1,2,4]Triazolo[4,3-a]pyridine as a New Player in the Field of IDO1 Catalytic Holo-Inhibitors.
    Fallarini S; Bhela IP; Aprile S; Torre E; Ranza A; Orecchini E; Panfili E; Pallotta MT; Massarotti A; Serafini M; Pirali T
    ChemMedChem; 2021 Nov; 16(22):3439-3450. PubMed ID: 34355531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and structure-activity relationship studies of 1-aryl-1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione derivatives as potent dual inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1) and trytophan 2,3-dioxygenase (TDO).
    Pan S; Zhou Y; Wang Q; Wang Y; Tian C; Wang T; Huang L; Nan J; Li L; Yang S
    Eur J Med Chem; 2020 Dec; 207():112703. PubMed ID: 32871341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of phosphonamidate IDO1 inhibitors for the treatment of non-small cell lung cancer.
    Du Q; Feng X; Wang Y; Xu X; Zhang Y; Qu X; Li Z; Bian J
    Eur J Med Chem; 2019 Nov; 182():111629. PubMed ID: 31445231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1).
    Fung SP; Wang H; Tomek P; Squire CJ; Flanagan JU; Palmer BD; Bridewell DJ; Tijono SM; Jamie JF; Ching LM
    Bioorg Med Chem; 2013 Dec; 21(24):7595-603. PubMed ID: 24262887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Inhibitors of Indoleamine 2,3-Dioxygenase 1: Molecular Modeling Studies, Synthesis, and Biological Evaluation.
    Coluccia A; Passacantilli S; Famiglini V; Sabatino M; Patsilinakos A; Ragno R; Mazzoccoli C; Sisinni L; Okuno A; Takikawa O; Silvestri R; La Regina G
    J Med Chem; 2016 Nov; 59(21):9760-9773. PubMed ID: 27690429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and preliminary structure-activity relationships of 1-Indanone derivatives as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors.
    Gao D; Li Y
    Bioorg Med Chem; 2017 Jul; 25(14):3780-3791. PubMed ID: 28526475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosidase inhibitory flavonoids from Sophora flavescens.
    Kim JH; Ryu YB; Kang NS; Lee BW; Heo JS; Jeong IY; Park KH
    Biol Pharm Bull; 2006 Feb; 29(2):302-5. PubMed ID: 16462036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4,6-Substituted-1H-Indazoles as potent IDO1/TDO dual inhibitors.
    Yang L; Chen Y; He J; Njoya EM; Chen J; Liu S; Xie C; Huang W; Wang F; Wang Z; Li Y; Qian S
    Bioorg Med Chem; 2019 Mar; 27(6):1087-1098. PubMed ID: 30773421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions.
    Tomek P; Palmer BD; Flanagan JU; Sun C; Raven EL; Ching LM
    Eur J Med Chem; 2017 Jan; 126():983-996. PubMed ID: 28011425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of novel naphthoquinone derivatives as IDO1 inhibitors.
    Pan L; Zheng Q; Chen Y; Yang R; Yang Y; Li Z; Meng X
    Eur J Med Chem; 2018 Sep; 157():423-436. PubMed ID: 30103191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.